Coegin Pharma (COEGIN) Status Update summary

Follicopeptide Q&A

• Online Q&A on the hair-growth project scheduled for Dec. 18, with Jens Eriksson, Lars Bukhave Rasmussen and John Zibert covering project progress.

• Sessions: Swedish, 14:30–15:00 CET; English, 18:00–18:30 CET (12:00–12:30 ET); open to all via Microsoft Teams or browser.

• Registration and advance questions due Dec. 17 at 17:00 CET (11:00 ET).

Product plans

• First hair-growth product series planned for launch in 2025, followed by a skin-pigmentation product in 2026.

• Pipeline also includes drug candidates for heart attack, leukemia and skin cancer.